Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Strategies for successful dose optimization in oncology drug development: a practical guide.
Journal: Journal of biopharmaceutical statistics
Published: August 11, 2024
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
Journal: Annals of hematology
Published: August 24, 2022
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial.
Journal: JACC. CardioOncology
Published: November 01, 2021
Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
Journal: American journal of hematology
Published: September 14, 2021
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Journal: The New England journal of medicine
Published: June 30, 2021
Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis.
Journal: Journal of clinical pharmacology
Published: June 23, 2021
Incidence rate of hospitalization and mortality in the first year following initial diagnosis of cardiac amyloidosis in the US claims databases.
Journal: Current medical research and opinion
Published: April 08, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 05, 2021
Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019.
Journal: European journal of haematology
Published: March 16, 2021
Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 02, 2020
Last Updated: 09/26/2026